Development and validation of a tool to understand health care professionals' attitudes towards deprescribing (HATD) in older adults with limited life expectancy
- PMID: 35296385
- DOI: 10.1016/j.sapharm.2022.03.002
Development and validation of a tool to understand health care professionals' attitudes towards deprescribing (HATD) in older adults with limited life expectancy
Abstract
Background: Understanding the perspective of health care professionals (HCPs) is significant to the implementation of deprescribing in older adults with limited life expectancy (LLE) but a tool to assess this is lacking.
Objective: This study aimed to develop and validate a survey tool for assessing HCPs attitudes towards deprescribing (HATD) in older adults with LLE.
Methods: An online survey was used to collect data to determine the psychometric properties of a 49-item questionnaire generated from literature review, expert opinion and pretesting. 108 HCPs (doctors, nurses and pharmacists) with experience or interest in palliative care or a member of a palliative care team/organisation completed the survey.
Results: Principal component analysis of the participants' data resulted in a 23-item questionnaire structured in five factors, named HATD tool. The factors were related to concerns about deprescribing (7 items), perceived burden of medications on patients (7 items), organisational support for deprescribing (4 items), assurance to deprescribing (2 items) and perceived involvement of patients in medication management (3 items). The HATD tool had valid descriptive statistics (Kaiser-Meyer-Olkin measure: 0.708; Bartlett's test of sphericity: p < 0.001, determinant: 1.35E-5; variance explained: 60.4%; nonredundant residuals with absolute values > 0.05: 39%). The reliability statistics of all the factors were ≥0.750 for both Cronbach's alpha (α) and composite reliability (CR) except for the patient-involvement factor (α = 0.644 but CR = 0.787).
Conclusions: The 23-itemed HATD tool is a valid and reliable tool to assess the attitudes and beliefs of HCPs towards deprescribing in older adults with LLE in the Australian setting.
Keywords: Aged; Attitudes; Deprescribing; Health care professionals; Palliative care; Principal component analysis.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
Translation, cultural adaptation and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire in Romanian older adults.Res Social Adm Pharm. 2023 Nov;19(11):1471-1479. doi: 10.1016/j.sapharm.2023.07.011. Epub 2023 Jul 20. Res Social Adm Pharm. 2023. PMID: 37495451
-
Translation, cross-cultural adaptation, and validation of the Danish version of the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire: Version for older people with limited life expectancy.Res Social Adm Pharm. 2021 Aug;17(8):1444-1452. doi: 10.1016/j.sapharm.2020.11.001. Epub 2020 Nov 4. Res Social Adm Pharm. 2021. PMID: 33279446
-
"… Above All, It's a Matter of This Person's Quality of Life": Health Care Professionals' Perspectives on Deprescribing in Older Patients With Limited Life Expectancy.Gerontologist. 2020 Apr 2;60(3):439-449. doi: 10.1093/geront/gnz116. Gerontologist. 2020. PMID: 31433836
-
Attitudes Towards Deprescribing Among Older Adults with Limited Life Expectancy and Their Relatives: A Systematic Review.Drugs Aging. 2020 Jul;37(7):503-520. doi: 10.1007/s40266-020-00774-x. Drugs Aging. 2020. PMID: 32537682
-
Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.Br J Clin Pharmacol. 2019 May;85(5):868-892. doi: 10.1111/bcp.13861. Epub 2019 Feb 27. Br J Clin Pharmacol. 2019. PMID: 30630219 Free PMC article.
Cited by
-
Differences in Factors Influencing Deprescribing between Primary Care Providers: Cross-Sectional Study.Int J Environ Res Public Health. 2023 Mar 11;20(6):4957. doi: 10.3390/ijerph20064957. Int J Environ Res Public Health. 2023. PMID: 36981865 Free PMC article.
-
Development and Validation of Comprehensive Healthcare Providers' Opinions, Preferences, and Attitudes towards Deprescribing (CHOPPED Questionnaire).Pharmacy (Basel). 2022 Jul 1;10(4):76. doi: 10.3390/pharmacy10040076. Pharmacy (Basel). 2022. PMID: 35893715 Free PMC article.
-
Improving the feasibility of deprescribing proton pump inhibitors: GPs' insights on barriers, facilitators, and strategies.Front Pharmacol. 2024 Sep 20;15:1468750. doi: 10.3389/fphar.2024.1468750. eCollection 2024. Front Pharmacol. 2024. PMID: 39372202 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources